Clinical genomic and molecular determinants of outcome in patients with Bone Marrow Failure Syndromes
2018-2021 (Doctoral Degree Fellowship): Clinical, genomic and molecular determinants of outcome in patients with Bone Marrow Failure Syndromes, Dr Lucy Fox, The University of Melbourne.
This project is the first scholarship in Australia to support a dedicated Doctor of Medical Science scholar to focus on describing, understanding and improving diagnosis of Bone Marrow Failure Syndromes using genomics evaluation. More accurate diagnosis of Bone Marrow Failure Syndromes using genomics evaluation underpins targeted treatment/s which will be associated with a greater chance of cure while avoiding harms and costs of inappropriate therapies. Working closely with the Aplastic Anaemia Registry (AAR) team, this new research role will also provide a valuable clinical resource to the AAR project team and contribute to analysis of Australian data for presentation and publication.
Related Projects
Improving capability and capacity of nurses to assess and manage young people with symptoms associated with acquired and inherited bone marrow failure syndromes.
2022-2024 (Fiona Riewoldt Nursing/Allied Health Fellowship): Improving capability and capacity of nurses to assess and manage young people with symptoms associated with acquired and inherited bone marrow failure syndromes. Rachel Edwards, ...
Read moreFunctional interrogation of Loci associated with the regulation of haematopoiesis
2019-2021 (Fellowship): The Alex Gadomski Fellowship. Functional interrogation of Loci associated with the regulation of haematopoiesis. Dr Kirsten Fairfax, Menzies Institute for Medical Research and University of Tasmania. To understand bone ...
Read moreA preclinical trial of next generation gene editing for the prevention of bone marrow failure in Fanconi Anaemia
2023- 2025 (Fellowship): The inaugural Captain Courageous Fellowship. A preclinical trial of next generation gene editing for the prevention of bone marrow failure in Fanconi Anaemia. Dr Astrid Glaser at the Genome Stability Unit of St Vincent’s ...
Read moreModelling consequences of cell abundance, heterogeneity and origin for autologous cell therapy in genetic Bone Marrow Failure Syndromes.
2020-2023 (Fellowship): Modelling consequences of cell abundance, heterogeneity and origin for autologous cell therapy in genetic Bone Marrow Failure Syndromes. Dr Parvathy Venugopal, Centre for Cancer Biology / University of South Australia. In ...
Read more